Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Medical Data Vision Co.Ltd. ( (JP:3902) ) is now available.
Medical Data Vision has revised its financial forecasts for the fiscal year ending December 31, 2025, due to lower-than-expected net sales and profits. Despite achieving record sales in the first half of the year, delays in the installation of the ‘ALPHA ･SALUS’ system and a careful examination of prospective projects have led to a significant downward revision. The company continues to invest in future growth, particularly by expanding its sales personnel, but expects operating income, ordinary income, and net income to be considerably lower than initially projected.
More about Medical Data Vision Co.Ltd.
Medical Data Vision Co., Ltd. operates in the healthcare industry, focusing on data utilization services and cloud-based medical checkup systems, such as the ‘ALPHA ･SALUS’.
Average Trading Volume: 262,870
Technical Sentiment Signal: Hold
Current Market Cap: Yen21.45B
For detailed information about 3902 stock, go to TipRanks’ Stock Analysis page.